Cagrilintide is a long-acting synthetic peptide that mimics amylin, a natural hormone released by the pancreas. It acts on the brain to increase satiety and delay gastric emptying, helping to control appetite. It is being studied for the treatment of obesity, either alone or in combination with semaglutide.
